Evidence map›Paper›PMID 40496109›Full record

ArticlePublic health challenges2025

Synthetic Cannabinoids in Sierra Leone: Understanding the Use of 'Kush' Among Youths and Its Socioeconomic Impact in Sierra Leone and Sub-Region.

Michael Lahai, Ahmed Vandy, Alvin Turay, Marie Kolipha-Kamara, Eugene Conteh

Abstract read
In one paragraph

Article in Public health challenges, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Michael LahaiFaculty of Pharmaceutical Sciences, College of Medicine and Allied Health Sciences University of Sierra Leone Freetown Sierra Leone.ORCID https://orcid.org/0000-0002-8605-3407
Ahmed VandyFaculty of Pharmaceutical Sciences, College of Medicine and Allied Health Sciences University of Sierra Leone Freetown Sierra Leone.ORCID https://orcid.org/0009-0008-2603-9989
Alvin TurayFaculty of Pharmaceutical Sciences, College of Medicine and Allied Health Sciences University of Sierra Leone Freetown Sierra Leone.ORCID https://orcid.org/0009-0002-6831-6848
Marie Kolipha-KamaraFaculty of Pharmaceutical Sciences, College of Medicine and Allied Health Sciences University of Sierra Leone Freetown Sierra Leone.ORCID https://orcid.org/0009-0004-5949-7960
Eugene ContehFaculty of Pharmaceutical Sciences, College of Medicine and Allied Health Sciences University of Sierra Leone Freetown Sierra Leone.ORCID https://orcid.org/0000-0003-1408-7680

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sierra Leone and neighbouring countries are prone to the proliferation of illicit drugs due to porous borders, weak regulatory frameworks, and the activities of transnational criminal syndicates. Among the emerging drug threats in the region is the synthetic cannabinoid known as 'Kush', which has gained immense popularity. The use of this drug has surged in recent years, particularly among Sierra Leonean youths, leading to the declaration of a national state of emergency by the government. The Ministry of Health and Sanitation has been tasked with establishing a National Task Force on drugs and substance abuse to identify treatment and mitigation measures to combat Kush addiction among affected individuals. This commentary highlights the current situation of Kush abuse among youths, its usage patterns and socioeconomic implications for Sierra Leone and the surrounding countries with key recommendations that will inform strategies for prevention, treatment and regulation.

Indexed as

illicit drugsKushsubstance use disordersynthetic cannabinoidsyouth mental health

Identifiers

PMID40496109
PMCPMC12039345

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.